Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein.
暂无分享,去创建一个
D. Ganem | R. Renne | D. Lukac | J. Kirshner | D. Ganem
[1] Jae U. Jung,et al. Identification of an Immunoreceptor Tyrosine-Based Activation Motif of K1 Transforming Protein of Kaposi’s Sarcoma-Associated Herpesvirus , 1998, Molecular and Cellular Biology.
[2] R. Sun,et al. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[3] F. Neipel,et al. The Immunogenic Glycoprotein gp35-37 of Human Herpesvirus 8 Is Encoded by Open Reading Frame K8.1 , 1998, Journal of Virology.
[4] T. Schulz,et al. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). , 1998, The Journal of general virology.
[5] R. Ricciardi,et al. Cloning and Functional Analysis of Kaposi’s Sarcoma-Associated Herpesvirus DNA Polymerase and Its Processivity Factor , 1998, Journal of Virology.
[6] Jeffrey N. Martin,et al. Sexual transmission and the natural history of human herpesvirus 8 infection. , 1998, The New England journal of medicine.
[7] B. Chandran,et al. Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs. , 1998, Virology.
[8] B. Chandran,et al. Identification and characterization of human herpesvirus-8 lytic cycle-associated ORF 59 protein and the encoding cDNA by monoclonal antibody. , 1998, Virology.
[9] B. Haar,et al. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8 , 1997, Journal of virology.
[10] D. Ganem,et al. The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus. , 1997, Virology.
[11] A. Haase,et al. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells , 1997, Journal of virology.
[12] J. Russo,et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[13] W. Zhong,et al. The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions , 1996, Journal of virology.
[14] M. McGrath,et al. The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[15] P. Simmonds,et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen , 1996, The Lancet.
[16] R. Brazas,et al. A Cellular Homolog of Hepatitis Delta Antigen: Implications for Viral Replication and Evolution , 1996, Science.
[17] P. Moore,et al. Kaposi's Sarcoma (KS)-associated herpesvirus and its role in KS. , 1996, Infectious agents and disease.
[18] S. Kenney,et al. Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[19] E. Operskalski,et al. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma–associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission , 1996, Nature Medicine.
[20] J. Phair,et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma , 1996, Nature Medicine.
[21] W. Zhong,et al. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[22] S. Rafii,et al. Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells , 1996, The Journal of experimental medicine.
[23] J. Pagano,et al. Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F , 1996, Journal of virology.
[24] M. McGrath,et al. Lytic growth of Kaposi's sarcoma–associated herpesvirus (human herpesvirus 8) in culture , 1996, Nature Medicine.
[25] A. Carbone,et al. Human herpesvirus 8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS. , 1996, The Journal of infectious diseases.
[26] D R Hoover,et al. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma , 1996, AIDS.
[27] E. Cesarman,et al. Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae , 1996, Journal of virology.
[28] C. Boshoff,et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma , 1995, The Lancet.
[29] F. Sigaux,et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. , 1995, Blood.
[30] E. Cesarman,et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.
[31] P. Moore,et al. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. , 1995, The New England journal of medicine.
[32] J. Ambroziak,et al. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. , 1995, Science.
[33] E. Cesarman,et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.
[34] H. Gruffat,et al. Characterization of the DNA-binding site repertoire for the Epstein-Barr virus transcription factor R. , 1994, Nucleic acids research.
[35] J M Hardwick,et al. The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16 , 1992, Journal of virology.
[36] G. Miller. The switch between latency and replication of Epstein-Barr virus. , 1990, The Journal of infectious diseases.
[37] H. Okayama,et al. High-efficiency transformation of mammalian cells by plasmid DNA. , 1987, Molecular and cellular biology.
[38] J. Countryman,et al. Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[39] V. Beral. Epidemiology of Kaposi's sarcoma. , 1991, Cancer surveys.